Adaptive Bio Ownership | Who Owns Adaptive Bio?


OverviewForecastRevenueFinancialsChartTranscripts

Adaptive Bio Ownership Summary


Adaptive Bio is owned by 49.07% institutional investors, 2.05% insiders, and 48.88% retail investors. Viking global investors lp is the largest institutional shareholder, holding 19.72% of ADPT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Adaptive Bio shares.

ADPT Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAdaptive Bio49.07%2.05%48.88%
SectorHealthcare Stocks 232.63%10.66%-143.29%
IndustryBiotech Stocks 382.12%10.42%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Viking global investors lp29.99M19.72%$448.71M
Blackrock funding, inc. /de13.33M8.79%$216.54M
Vanguard group11.28M7.40%$183.22M
Millennium management6.29M4.27%$37.72M
Ameriprise financial5.97M3.93%$89.34B
Westfield capital management co lp4.06M2.68%$65.94M
Geode capital management3.51M2.31%$57.04M
Aristotle atlantic partners3.13M2.06%$46.78M
Lord, abbett3.08M2.03%$50.03M
State street3.08M2.02%$46.07M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Blue water life science advisors, lp2.15M29.28%$32.09M
Iron triangle partners lp1.82M3.87%$27.24M
Catalio capital management, lp884.89K2.45%$13.24M
Essex investment management638.46K1.46%$9.55M
Aristotle atlantic partners3.13M1.36%$46.78M
Beaconlight capital171.60K1.27%$2.57M
Viking global investors lp29.99M1.17%$448.71M
Rhenman & partners asset management ab495.00K0.82%$7.41B
Affinity wealth management314.35K0.73%$5.11M
Eam investors351.30K0.64%$5.71M

Top Buyers

HolderShares% AssetsChange
Westfield capital management co lp4.06M0.27%4.06M
Ameriprise financial5.97M0.02%2.73M
Arrowstreet capital, limited partnership2.44M0.02%2.06M
Lord, abbett3.08M0.15%1.85M
Jennison associates2.67M0.03%1.36M

Top Sellers

HolderShares% AssetsChange
Rubric capital management lp---6.26M
Braidwell lp736.01K0.33%-3.13M
Millennium management6.29M0.02%-3.11M
Macquarie group---2.10M
Nikko asset management americas1.95M0.37%-1.70M

New Positions

HolderShares% AssetsChangeValue
Westfield capital management co lp4.06M0.27%4.06M$65.94M
Summit partners public asset management998.25K0.31%998.25K$14.93M
Next century growth investors531.32K0.58%531.32K$7.95M
Wellington management group llp501.08K0.00%501.08K$7.50M
Rhenman & partners asset management ab495.00K0.82%495.00K$7.41B

Sold Out

HolderChange
Wealthspire advisors-7.00
Ronald blue trust-21.00
Prestige wealth management group-25.00
Birch capital management-40.00
Stephens consulting-45.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025188-30.88%74,799,607-48.57%490.54%97-35.33%60-24.05%
Sep 30, 20252575.33%143,897,903-2.89%941.00%139-7724.19%
Jun 30, 20252437.05%148,113,052-1.78%970.95%13722.32%63-4.55%
Mar 31, 20252278.10%152,848,9696.73%1021.09%1130.89%6544.44%
Dec 31, 202420911.17%143,202,0650.07%971.03%11114.43%452.27%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv4.58M2.98%12.58K
Vanguard US Total Market Shares ETF4.19M2.82%-
iShares Russell 2000 ETF3.61M2.35%1.19M
Nikko AM ARK Pstv Chg Innovt P JPY Acc3.56M2.34%-116.30K
Columbia Large Cap Growth SMA Cmp3.25M2.19%3.25M
Columbia Large Cap Growth V3.25M2.19%3.25M
Columbia Large Cap Growth3.25M2.19%3.25M
Columbia Cornerstone Growth SMA3.25M2.14%3.25M
Columbia Small Cap Growth Inst2.19M1.44%193.43K
Nikko Gbl All Biological Genome Eq MF2.06M1.40%-121.82K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 18, 2026RUBINSTEIN JULIE President and COOSell$251.21K
Mar 17, 2026RUBINSTEIN JULIE President and COOSell$255.40K
Mar 16, 2026RUBINSTEIN JULIE President and COOSell$255.59K
Mar 11, 2026RUBINSTEIN JULIE President and COOSell$1.61M
Mar 12, 2026RUBINSTEIN JULIE President and COOSell$172.53K

Insider Transactions Trends


DateBuySell
2026 Q1-41
2025 Q4-16
2025 Q2-3
2025 Q1-25
2024 Q4-1

ADPT Ownership FAQ


Who Owns Adaptive Bio?

Adaptive Bio shareholders are primarily institutional investors at 49.07%, followed by 2.05% insiders and 48.88% retail investors. The average institutional ownership in Adaptive Bio's industry, Biotech Stocks , is 382.12%, which Adaptive Bio falls below.

Who owns the most shares of Adaptive Bio?

Adaptive Bio’s largest shareholders are Viking global investors lp (29.99M shares, 19.72%), Blackrock funding, inc. /de (13.33M shares, 8.79%), and Vanguard group (11.28M shares, 7.40%). Together, they hold 35.91% of Adaptive Bio’s total shares outstanding.

Does Blackrock own Adaptive Bio?

BlackRock is not among the top 10 institutional shareholders of Adaptive Bio.

Who is Adaptive Bio’s biggest shareholder by percentage of total assets invested?

Blue water life science advisors, lp is Adaptive Bio’s biggest shareholder by percentage of total assets invested, with 29.28% of its assets in 2.15M Adaptive Bio shares, valued at 32.09M$.

Who is the top mutual fund holder of Adaptive Bio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Adaptive Bio shares, with 2.98% of its total shares outstanding invested in 4.58M Adaptive Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools